Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Chemoradiation with Cisplatin, IFN-alpha, and 5-FU for Pancreatic Cancer
NCT00068575Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2002
- Primary completion
- Dec 2010
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa-2b in pancreatic adenocarcinoma (PDAC), sponsored by University of Texas MD Anderson Cancer Center. Started May 2002; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00068575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00068575.